We represented a behavioral health provider in an FCA action in the Western District of Texas involving allegations of improper billing for medications. We ultimately obtained dismissal of the FCA allegations. U.S. ex rel. Henry v. CRC Health Corp. et al., No. 13-cv-117 (W.D. Tex.).
U.S. ex rel. Henry v. CRC Health Corp. et al.
You Also May Be Interested In:
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee